NO20040995L - Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus - Google Patents

Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus

Info

Publication number
NO20040995L
NO20040995L NO20040995A NO20040995A NO20040995L NO 20040995 L NO20040995 L NO 20040995L NO 20040995 A NO20040995 A NO 20040995A NO 20040995 A NO20040995 A NO 20040995A NO 20040995 L NO20040995 L NO 20040995L
Authority
NO
Norway
Prior art keywords
subunit vaccine
necrosis virus
pancreatic necrosis
infectious pancreatic
infectious
Prior art date
Application number
NO20040995A
Other languages
English (en)
Inventor
Vikram N Vakharia
Original Assignee
Univ Maryland Biotech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland Biotech Inst filed Critical Univ Maryland Biotech Inst
Publication of NO20040995L publication Critical patent/NO20040995L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20040995A 2001-08-10 2004-03-09 Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus NO20040995L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31148801P 2001-08-10 2001-08-10
PCT/US2002/025185 WO2003013597A1 (en) 2001-08-10 2002-08-12 Sub-unit vaccine for infectious pancreatic necrosis virus

Publications (1)

Publication Number Publication Date
NO20040995L true NO20040995L (no) 2004-04-29

Family

ID=23207100

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040995A NO20040995L (no) 2001-08-10 2004-03-09 Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus

Country Status (5)

Country Link
US (1) US6936256B2 (no)
EP (1) EP1420819B1 (no)
CA (1) CA2457349A1 (no)
NO (1) NO20040995L (no)
WO (1) WO2003013597A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE467358T1 (de) * 2001-03-23 2010-05-15 Advanced Bionutrition Corp Verfahren zur herstellung eines futtermittels enthaltend bakterien für aquakultur und seiner verwendung
ES2217967B1 (es) * 2003-03-31 2006-01-01 Consejo Sup. Investig. Cientificas Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
GB2434367B (en) * 2004-10-05 2010-05-12 Diversa Corp Improved vaccines
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
GB2477712A (en) * 2006-12-20 2011-08-17 Advanced Bionutrition Corp Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
US9139618B2 (en) * 2010-12-29 2015-09-22 Intervet Inc. Salmonid alphavirus protein E2
EP2870238A4 (en) * 2012-07-05 2016-03-09 Ohio State Innovation Foundation COMPOSITIONS AND METHODS ASSOCIATED WITH VIRAL VACCINES
US9623099B2 (en) 2012-09-26 2017-04-18 Fvg Limited Subunit immersion vaccines for fish
GB201309664D0 (en) * 2013-05-30 2013-07-17 Univ Aberdeen Fish vaccine
GB201400311D0 (en) * 2014-01-08 2014-02-26 Aqua Gen As Treating Susceptibility
CA2954876A1 (en) * 2014-07-11 2016-01-14 Fundacion Fraunhofer Chile Research Agent with antiviral properties for preventing or treating individuals exposed to a virus of the birnaviridae family
US10792354B2 (en) 2017-12-31 2020-10-06 University Of Maryland Baltimore County Feed additive composition for immunoprotection of fish against infectious viral species

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
DE69531891D1 (de) * 1994-10-18 2003-11-13 Akzo Nobel Nv Virus, welches die Pankreas-Krankheit bei Fischen verursacht
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
CA2324478C (en) * 1998-03-31 2011-08-23 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
JP4323720B2 (ja) * 1998-05-08 2009-09-02 インターベツト・インターナシヨナル・ベー・ベー 魚膵臓病ウイルス構造タンパク質およびその使用

Also Published As

Publication number Publication date
EP1420819A1 (en) 2004-05-26
US20030072772A1 (en) 2003-04-17
EP1420819B1 (en) 2008-05-28
EP1420819A4 (en) 2005-09-28
CA2457349A1 (en) 2003-02-20
WO2003013597A1 (en) 2003-02-20
US6936256B2 (en) 2005-08-30

Similar Documents

Publication Publication Date Title
CY2016018I1 (el) Εμβολιο κατα του ιου του δυτικου νειλου
NO20040995L (no) Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus
EP1603590A4 (en) INFLUENZA VIRUS VACCINE
IS7830A (is) Bóluefni gegn lifrarbólgu C veiru (HCV)
FR14C0016I2 (fr) Vacccin west nile
ATE553775T1 (de) Impstoffzusammesetzung
ATE420159T1 (de) Grippe-impfstoffzusammensetzung
NO20040322L (no) Virus-polymerase-inhibitorer
NO20044326D0 (no) Virale antigener
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
NO20024172D0 (no) Vaksine
NO20033882D0 (no) Vaksine
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
DK1523329T3 (da) Viruspartikeladjuvant
NO20030239D0 (no) Modifisert virus
AU2003294757A8 (en) Formulations useful against hepatitis c virus infections
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
IS2797B (is) Bóluefni gegn ISA-veiru
AU2002355428A1 (en) Sub-unit vaccine for infectious pancreatic necrosis virus
SI1436397T1 (sl) Cepivo proti virusu hepatitisa C
NO20012126D0 (no) HIV-vaksine
DK2258850T3 (da) Rekombinante virusbaserede malariavacciner
DK1299395T3 (da) Oxazinoquinoloner til behandling af virusinfektioner
AU2002319246A1 (en) White spot syndrome virus vaccine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application